Clinical Trial Update: Once Daily Metronidazole for Perforated Appendicitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating once-daily metronidazole for perforated appendicitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendicitis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Ahmed Nasr | Conditions: Appendicitis | Phase 4 | Status: WITHDRAWN